Announcements Trials
Browse Landscape

Phase

Phase 3 15Phase 4 12Phase NA 7Phase 2 5Phase 1/2 3Phase EARLY_PHASE1 2Phase 2/3 2Phase 1 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Classical hematology 1

Conditions

Urologic Diseases 1Urinary Retention 1Urinary Bladder Neoplasms 1Thrombocytopenia 1Prostatic Neoplasms 1Patient Satisfaction 1Neoplasms 1Hemostatic Disorders 1Hemorrhage 1Hematuria 1

Interventions

Cyclophosphamide 250Radiotherapy 172pembrolizumab 155Carboplatin 147Gemcitabine 139Nivolumab 135Paclitaxel 129Dexamethasone 119Cisplatin 118fludarabine 115Rituximab 104Lenalidomide 103Bevacizumab 99Docetaxel 97Capecitabine 97fludarabine phosphate 92Temozolomide 89Cytarabine 89Oxaliplatin 87Etoposide 82Filgrastim 77Irinotecan 73Doxorubicin 73venetoclax 70Peripheral Blood Stem Cell Transplantation 68Fluorouracil 68Radiosurgery 66Melphalan 66Everolimus 66Bortezomib 66

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × OTHER × Tranexamic Acid × Clear all
NCT06023212 2025-02-10

Tranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1/2 Recruiting
150 enrolled

Hemorrhage

NCT04555343 2021-11-05

Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention

Fraser Health

Phase 1/2 Completed
14 enrolled
Genitourinary

Urinary Bladder Neoplasms, Hematuria, Prostatic Neoplasms, Urologic Diseases, Urinary Retention, Patient Satisfaction

NCT03806556 2021-09-20

A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia

University of Pittsburgh

Phase 1/2 Terminated
11 enrolled 15 charts
Classical hematology

Neoplasms, Thrombocytopenia, Hemostatic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡